| Abstract: | The Cape Cod Symposium on Addictive Disorders (CCSAD), an annual conference held in Hyannis, Massachusetts, in early September when the weather is still nice but the summer crowds have left, is sometimes considered a meet‐up for rehab marketers more than an opportunity to get educated on the latest clinical advances. This year, a plenary presentation on opioid use disorders was to be given by Andrea G. Barthwell, M.D., former deputy director of demand reduction at the White House Office of National Drug Control Policy, but she couldn't make it due to sickness. Instead, a panel of experts affiliated with the American Society of Addiction Medicine (ASAM), which sponsored the talk, stepped in, first going through her slides (so the continuing education credits would be valid) and then holding a town hall–type colloquy. The hot‐button issue of distrust of medication by a treatment community rooted in abstinence was the focus. |
